Minnesota parents and teachers say the ICE arrests are not only robbing students of their opportunity to learn, but also of ...

The American telehealth company announced the launch of a compounded weight-loss pill for €41, drawing criticism from Novo ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

Serena Williams said that roughly a year after starting a weight loss drug, she is the healthiest she has ever been and has ...

The world is in the middle of a peptide drug revolution. These short chains of amino acids—the building blocks of ...

Serena Williams' Super Bowl LX ad with Ro is sparking debate, as it promotes weight loss with GLP-1s. Here's what to know.

“This is a miracle,” the 51-year-old tells Women's Health.

Multiple class action lawsuits claim SLM Corporation (NasdaqGS:SLM) understated loan delinquencies and overstated the strength of its loss mitigation programs. Plaintiffs allege investors were misled ...

PF'3944 is an ultra-long-acting fully biased GLP-1 receptor agonist (RA). It is being developed as a single agent weekly and as a monthly therapy, and in combination with various peptides including an ...

Sales of weight loss medicines like Ozempic and Mounjaro have sky-rocketed in South Africa in recent years, although they remain too expensive for most people who might benefit from the jabs. In the ...

Revita-treated patients experienced sustained weight maintenance, improved cardiometabolic profile, and reduced food cravings at 6 months ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 2b VESPER-3 study investigating monthly maintenance dosing of its ...